Human polymorphonuclear leukocytes inhibit Aspergillus fumigatus conidial growth by lactoferrin-mediated iron depletion.
Aspergillus fumigatus, a common mold, rarely infects humans, except during prolonged neutropenia or in cases of chronic granulomatous disease (CGD), a primary immunodeficiency caused by mutations in the NADPH oxidase that normally produces fungicidal reactive oxygen species. Filamentous hyphae of Aspergillus are killed by normal, but not CGD polymorphonuclear leukocytes (PMN); however, the few studies on PMN-mediated host defenses against infectious conidia (spores) of this organism have yielded conflicting results, some showing that PMN do not inhibit conidial growth, with others showing that they do, most likely using reactive oxygen species. Given that CGD patients are exposed daily to hundreds of viable A. fumigatus conidia, yet considerable numbers of them survive years without infection, we reasoned that PMN use ROS-independent mechanisms to combat Aspergillus. We show that human PMN from both normal controls and CGD patients are equipotent at arresting the growth of Aspergillus conidia in vitro, indicating the presence of a reactive oxygen species-independent factor(s). Cell-free supernatants of degranulated normal and CGD neutrophils both suppressed fungal growth and were found to be rich in lactoferrin, an abundant PMN secondary granule protein. Purified iron-poor lactoferrin at concentrations occurring in PMN supernatants (and reported in human mucosal secretions in vivo) decreased fungal growth, whereas saturation of lactoferrin or PMN supernatants with iron, or testing in the presence of excess iron in the form of ferritin, completely abolished activity against conidia. These results demonstrate that PMN lactoferrin sequestration of iron is important for host defense against Aspergillus.
Zarember
Kol A
KA
Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Sugui
Janyce A
JA
Chang
Yun C
YC
Kwon-Chung
Kyung J
KJ
Gallin
John I
JI
D000935:Antifungal Agents / Q000378:metabolism / Q000494:pharmacology; D001232:Aspergillus fumigatus / Q000166:cytology / Q000254:growth & development* / Q000276:immunology*; D015550:Cell Degranulation / Q000276:immunology; D002478:Cells, Cultured; D002923:Cilia / Q000276:immunology / Q000382:microbiology; D006105:Granulomatous Disease, Chronic / Q000276:immunology / Q000378:metabolism / Q000473:pathology; D006801:Humans; D007501:Iron / Q000378:metabolism*; D007781:Lactoferrin / Q000502:physiology*; D009093:Mucus / Q000276:immunology / Q000382:microbiology; D009504:Neutrophils / Q000276:immunology* / Q000378:metabolism* / Q000382:microbiology; D013172:Spores, Fungal / Q000166:cytology / Q000254:growth & development* / Q000276:immunology*
D000935:Antifungal Agents; D007501:Iron; D007781:Lactoferrin